OPPI appoints Bhushan Akshikar as President Ruchika Sharma27 Sept 2024 12:25 PM ISTMumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in...
Submit safety data on South Asian subjects with Plaque Psoriasis: CDSCO Panel Tells Johnson & Johnson on Ustekinumab Dr. Divya Colin24 Sept 2024 6:00 PM ISTNew Delhi: In line with the proposal presented by the drug major Johnson and Johnson proposal for approval of additional indication with waiver of...
JnJ Tremfya receives USFDA approval for adults with moderately to severely active ulcerative colitis Ruchika Sharma12 Sept 2024 12:30 PM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
CDSCO Panel Approves Johnson and Johnson's Protocol Amendment Proposal to Study JNJ-77242113 Dr. Divya Colin19 July 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
CDSCO Panel Approves J&J's Protocol Amendment Proposal For Amivantamab, Lazertinib combination Dr. Divya Colin14 April 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Single tablet combo of macitentan and tadalafil receives US FDA approval for pulmonary artery hypertension Dr. Kamal Kant Kohli25 March 2024 3:30 AM ISTUSA: A single-tablet combination of macitentan and tadalafil (Opsynvi) has received approval from the US Food and Drug Administration (FDA) as the...
CDSCO Panel grants J&J Protocol Amendment proposal to study anticancer drug Amivantamab and Lazertinib Dr. Divya Colin9 Jan 2024 5:45 PM ISTNew Delhi: Regarding the study of Amivantamab and Lazertinib in combination with platinum-based chemotherapy compared with platinum-based chemotherapy...
J&J Gets CDSCO Panel Nod to study anti-cancer drug Talquetamab Dr. Divya Colin22 Dec 2023 6:00 PM ISTNew Delhi: The drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit Clarification for Weight-based calculated fixed dose: CDSCO panel Tells J&J Over Teclistamab Dr. Divya Colin21 Aug 2023 6:00 PM ISTNew Delhi: Based on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the...
J&J boosts profit forecasting as it invests in chemotherapy, medical devices Kajal Rajput21 July 2023 3:08 PM ISTNew Delhi: Johnson and Johnson raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its...
